Beyond Traditional Screening: The Commercial Potential of Contrast-Enhanced Mammography

0
6

Can Contrast-Enhanced Mammography (CEM) bridge the gap between screening and MRI?

Contrast-enhanced mammography (CEM) is emerging as a powerful, cost-effective alternative to Breast MRI for high-risk patients. While MRI remains the gold standard for sensitivity, its high cost and limited availability create access barriers. CEM utilizes existing mammography equipment with the addition of intravenous contrast agents, providing functional vascular information similar to MRI but at a fraction of the cost.

For strategy heads at diagnostic centers, CEM offers a way to diversify their service portfolio without investing millions in a new MRI suite. It allows for more efficient preoperative planning and better assessment of treatment response in oncology patients, making it a high-value tool for integrated breast centers.

How are Breast Cancer Diagnostic Trends shifting toward functional imaging?

Current Breast Cancer Diagnostic Trends indicate a move toward "precision diagnostics." In 2024, clinicians are looking for ways to reduce the "grey area" of inconclusive mammograms. CEM provides the functional data necessary to make definitive decisions, reducing the time from screening to treatment—a key metric for patient outcomes and hospital reputation.

What are the procurement considerations for CEM?

Implementing CEM requires hardware that supports dual-energy acquisition and the integration of contrast injectors. Procurement teams must also consider the additional training required for technicians and the logistics of contrast agent management. In 2025, we expect a rise in "upgrade kits" that allow existing 3D systems to perform CEM.

Criteria

Standard Digital Mammography

Contrast-Enhanced Mammography (CEM)

Information Type

Morphological (Anatomy)

Functional (Vascularity)

Cost per Scan

Low

Moderate

Procedure Time

5-10 minutes

10-15 minutes

Strategic Outlook for 2025

In 2025, CEM is projected to become the standard of care for supplemental screening in women with dense breasts who cannot undergo MRI. Diagnostic centers that adopt this early will capture a high-margin patient segment and differentiate themselves in an increasingly competitive imaging market.

Author: Sofiya Sanjay

Designation: Healthcare Research Consultant, Market Research Future

About: At Market Research Future (MRFR), we enable organizations to unravel complex industries through Cooked Research Reports (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact: 99 Hudson Street, 5th Floor, New York, NY 10013, USA | (855) 661-4441 (US) | info@marketresearchfuture.com

Zoeken
Categorieën
Read More
Health
Navigating Regulatory Standards and Safety Protocols in the IV Hydration Therapy Industry
As the popularity of intravenous therapy has surged in 2025, the industry has seen a significant...
By Anuj Mrfr 2025-12-18 12:30:48 0 53
Other
North America Sickle Cell Disease Market Size Projected to Reach USD 4.01 Billion by 2032
The North America Sickle Cell Disease Market encompasses the medical treatments, diagnostics, and...
By Shiv Mehara 2025-12-16 05:08:05 0 35
Other
Europe Charge-Coupled Device (CCD) Imagers Market Trends: Growth, Share, Value, Size, and Analysis By 2032
Comprehensive Outlook on Executive Summary Europe Charge-Coupled Device (CCD) Imagers Market...
By Travis Rosher 2025-10-28 07:18:24 0 208
Spellen
Global Tablet Coatings Market Size, Share, Industry Insights, Trends, Outlook, Opportunity Analysis Forecast To 2032
The market research for the global Tablet Coatings market is an accumulation of...
By Priyanka Sarvade 2025-11-11 09:56:50 0 178
Crafts
Essential Hoodie Canada Designed for Daily Wear Versatility
Essential Hoodie Canada is designed for daily wear versatility, blending modern streetwear...
By Essentials Hoodie 2025-12-20 21:14:47 0 61